JP2018535277A - 耳科学的予防および処置のための組成物および方法 - Google Patents

耳科学的予防および処置のための組成物および方法 Download PDF

Info

Publication number
JP2018535277A
JP2018535277A JP2018547866A JP2018547866A JP2018535277A JP 2018535277 A JP2018535277 A JP 2018535277A JP 2018547866 A JP2018547866 A JP 2018547866A JP 2018547866 A JP2018547866 A JP 2018547866A JP 2018535277 A JP2018535277 A JP 2018535277A
Authority
JP
Japan
Prior art keywords
patient
surfactant
ear
surfactant composition
administering
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018547866A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018535277A5 (enExample
Inventor
フレッシャー，グレゴリー・ジェイ．
ターケル，キャサリン・クリスプ
モートーン，アラン・ジェイ．
チャンドラセカール，スジャナ・エス．
Original Assignee
ノヴァス・セラピューティクス・インコーポレーテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ノヴァス・セラピューティクス・インコーポレーテッド filed Critical ノヴァス・セラピューティクス・インコーポレーテッド
Publication of JP2018535277A publication Critical patent/JP2018535277A/ja
Publication of JP2018535277A5 publication Critical patent/JP2018535277A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2018547866A 2015-11-30 2016-11-30 耳科学的予防および処置のための組成物および方法 Pending JP2018535277A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201562260732P 2015-11-30 2015-11-30
US201562260734P 2015-11-30 2015-11-30
US201562260742P 2015-11-30 2015-11-30
US62/260,734 2015-11-30
US62/260,732 2015-11-30
US62/260,742 2015-11-30
PCT/US2016/064190 WO2017095905A1 (en) 2015-11-30 2016-11-30 Compositions and methods for otologic prophylaxis and treatment

Publications (2)

Publication Number Publication Date
JP2018535277A true JP2018535277A (ja) 2018-11-29
JP2018535277A5 JP2018535277A5 (enExample) 2020-01-16

Family

ID=58778000

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018547866A Pending JP2018535277A (ja) 2015-11-30 2016-11-30 耳科学的予防および処置のための組成物および方法

Country Status (8)

Country Link
US (1) US20170151173A1 (enExample)
EP (1) EP3383369A4 (enExample)
JP (1) JP2018535277A (enExample)
KR (1) KR20180105129A (enExample)
AU (1) AU2016365219A1 (enExample)
CA (1) CA3006563A1 (enExample)
MX (1) MX2018006575A (enExample)
WO (1) WO2017095905A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020142420A1 (en) * 2018-12-31 2020-07-09 Novus Therapeutics, Inc. Novel surfactant-lipid alloy drug substance, methods of making the same, and pharmaceutical compositions comprising the same

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997029738A1 (en) * 1996-02-16 1997-08-21 The Administrators Of The Tulane Educational Fund Methods and compositions for treating eustachian tube dysfunction by inhalation
JP2003514842A (ja) * 1999-11-28 2003-04-22 サイエンティフィック ディヴェロップメント アンド リサーチ インコーポレイテッド 中耳炎を処置する組成物及び方法
JP2005511648A (ja) * 2001-12-04 2005-04-28 サイエンティフィック デベロプメント アンド リサーチ， インコーポレイテッド 中耳炎の処置のための組成物および方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5954682A (en) * 1996-09-25 1999-09-21 Advanced Medical Instruments Therapeutic applicator apparatus and method
CO4910145A1 (es) * 1996-10-01 2000-04-24 Smithkline Beecham Corp Uso
ATE271048T1 (de) * 1997-11-24 2004-07-15 Procter & Gamble 5-(2-imidazolinylamino)-benzimidazol derivate, deren herstellung und deren verwendung als .alpha.-adrenoceptor agonisten mit verbesserter metabolischer stabilität
US20060207596A1 (en) * 2005-03-18 2006-09-21 Fairfield Clinical Trials, Llc Device and method for delivery of combination nasal medication
US8568790B2 (en) * 2006-05-31 2013-10-29 Medihoney Pty Ltd. Medicinal compositions containing honey
US8343464B2 (en) * 2010-04-30 2013-01-01 Burns Phillip E Composition and method for treating eustachian tube dysfunction
SG11201406208QA (en) * 2012-05-03 2014-11-27 Janssen Sciences Ireland Uc Polyinosinic-polycytidylic acid (poly (i:c)) formulations for the treatment of upper respiratory tract infections
EA201590124A1 (ru) * 2012-06-29 2015-06-30 Майкродоуз Терапьютикс, Инк. Композиции и способы лечения или предупреждения пневмовирусной инфекции и связанных заболеваний

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997029738A1 (en) * 1996-02-16 1997-08-21 The Administrators Of The Tulane Educational Fund Methods and compositions for treating eustachian tube dysfunction by inhalation
JP2003514842A (ja) * 1999-11-28 2003-04-22 サイエンティフィック ディヴェロップメント アンド リサーチ インコーポレイテッド 中耳炎を処置する組成物及び方法
JP2005511648A (ja) * 2001-12-04 2005-04-28 サイエンティフィック デベロプメント アンド リサーチ， インコーポレイテッド 中耳炎の処置のための組成物および方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
THE LARYNGOSCOPE, 2004, VOL.114, P.472-485, JPN6020045968, ISSN: 0004595847 *

Also Published As

Publication number Publication date
WO2017095905A1 (en) 2017-06-08
EP3383369A4 (en) 2019-06-12
US20170151173A1 (en) 2017-06-01
EP3383369A1 (en) 2018-10-10
AU2016365219A1 (en) 2018-07-05
KR20180105129A (ko) 2018-09-27
MX2018006575A (es) 2018-12-06
CA3006563A1 (en) 2017-06-08

Similar Documents

Publication Publication Date Title
Laube Devices for aerosol delivery to treat sinusitis
EP2482903B1 (en) Improved method for treatment of patients with cystic fibrosis
KR20230019268A (ko) 액체 제형 조성물, 약제 전달 장치, 및 이들의 제조 및 사용 방법
US9861647B2 (en) Calcium glycerophosphate for treating and preventing respiratory diseases or conditions
Vlckova et al. Effective treatment of mild-to-moderate nasal polyposis with fluticasone delivered by a novel device
WO1997029738A1 (en) Methods and compositions for treating eustachian tube dysfunction by inhalation
US20090277459A1 (en) Nasal Device Useful for Prevention of Snoring and Sleeping Apnea
Owens et al. Tympanic membrane rupture with nitrous oxide anesthesia
US20170151173A1 (en) Compositions and methods for otologic prophylaxis and treatment
Grewal et al. Tuberculous otitis media presenting as complications: report of 18 cases
CA2701388C (en) Calcium glycerophosphate for treating and preventing respiratory diseases or conditions
BR112021009572A2 (pt) métodos e composições para prevenção ou tratamento de exacerbações agudas com imunoglobulina policlonal
US20110268669A1 (en) Composition and method for treating eustachian tube dysfunction
RU2550966C1 (ru) Средство и способ лечения экссудативного среднего отита у детей
Hatch et al. Treatment options in the child with a chronic cough
Rashid Rationale and feasibility of intranasal delivery of drugs to the eustachian tube orifice
KR20160133640A (ko) 코 보호 및 코 질병 치료를 위한 인중 부착 밴드의 제작 방법
Syed et al. Acute management of croup in children
Banasiak et al. Clinical profile of chronic bronchial asthma patients in Poland: results of the PROKSAL study
Yehia Mostafa et al. Topical intranasal corticosteroids compared with oral steroids in the Treatment of Eustachian tube dysfunction in children
MacKenzie Otitic and sinus barotrauma
Putri et al. A 55-Year-Old Man With Shortness, Cough And Fever: A Case Report
MD1816Z (ro) Metodă de tratament al otitei seroase la copii
Diamant et al. Congenital Choanal Atresia: Report of a Clinical Series with Special References to Early Symptoms and Therapy
Praveena Clinical Study of Septal Deviation and its Association with Sinusitis

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180830

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A712

Effective date: 20180830

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20180830

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20191202

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20191202

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20201130

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20210301

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210430

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20210916

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20220411